Patient-reported outcomes (PROs) provide essential safety and tolerability data to inform clinical care and regulatory decisions; however, their use in early phase settings and integration with clinical and wearable data to target interventions is limited. Furthermore, trials using PROs often fail to address cultural or health specificities of under-served populations. This theme will address “unacceptable health inequalities” by facilitating participation in patient-centred research from under-served populations. PROs are particularly important in chronic/inflammatory disease, as improvements in clinical outcomes may be challenging to measure, and curative therapies not yet widely available. The target of intervention in these conditions may be to reduce symptom burden and improve quality of life.
Professor Mel Calvert
Associate Professor Lee Aiyegbusi